Actively Recruiting
Validation of Urine HPV Testing for Cervical Cancer Screening in Women Living With HIV in South Africa
Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2026-09-30
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are exploring the use of urine samples for cervical cancer screening in women living with HIV, a group at a significantly higher risk of invasive cervical cancer compared to women without HIV. This study focuses on validating urine HPV testing in low- and middle-income countries, where data on HIV-infected women is currently lacking. It aims to compare urine HPV testing with other screening methods to determine its usefulness and accuracy. Participants will provide three types of samples for high-risk HPV testing urine, self-collected vaginal specimens using a small brush, and provider-collected cervical samples. This single-arm study evaluates whether urine HPV testing can match the sensitivity and specificity of the other two sample types for detecting cervical precancerous changes, specifically cervical intra-epithelial neoplasia grade 2 or worse CIN2. During the study, women will collect their own urine and vaginal samples, while healthcare providers will collect cervical samples. The researchers will assess the clinical performance of HPV testing on these samples at the entry visit, approximately four weeks after enrollment. They will measure the detection of CIN2 and CIN3 or worse lesions, as well as the proportion of participants testing positive for high-risk HPV. The study will continue until August 2027.
CONDITIONS
Brief Title
Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
Research Team
C
Cheryl Hendrickson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here